July 13, 2012
Week in Review: M&A Trends and MedCity Converge Conference in Philadelphia
We’ve made it past the halfway mark of 2012, giving us a chance to look back and review how the year is shaping up so…
Posted by
Safeguard Insights
July 13, 2012
Putting Growth Capital to Work in Philadelphia
On average, Safeguard Scientifics evaluates more than a thousand business plans each year—that’s 20 business plans per week. Last year, we chose to partner with…
Posted by
Alverix Technology Key to Landmark Flu Test from BD
In the rush of the holidays, you may have missed some recent news from Safeguard Scientifics’ life sciences partner company Alverix. On December 20, 2011,…
Posted by
VIDEO: Recap of Growth at AdvantEdge Healthcare Solutions, Bridgevine and MediaMath
Earlier this quarter at Safeguard Scientifics’ Investor Day, we provided further transparency into three of our technology partner companies, which have also experienced tremendous growth:…
Posted by
A Focus on Life Sciences
Safeguard Scientifics has a unique and consistent approach to putting capital to work in the life sciences sector. We target capital efficient diagnostic companies that…
Posted by
The Power of emPower!
PixelOptics’ emPower! eyewear is the world’s first and only electronic focusing eyeglasses—focusing faster than the blink of an eye. The technology is embedded inside the lenses and…
Posted by
Opportunity in the Migraine Market for NuPathe
Ninety percent of migraine sufferers experience nausea, while 60 percent experience vomiting because of their migraine. As a result, today’s most common migraine treatments that…
Posted by
Can Social Media Directly Impact Share Price?
We are only beginning to realize the true impact of a robust social presence in the field of Investor Relations. Even as more and more…
Posted by
Communicating Value and Increasing Transparency
Cash on our balance sheet may be growing with every well-timed exit transaction and positive momentum is driving Safeguard’s stock price upward; however, our IR…
Posted by
